基本信息
浏览量:4
职业迁徙
个人简介
Biography
Joseph N. Contessa, MD, PhD, a radiation oncologist, is the director of Yale Medicine’s Central Nervous System Radiotherapy Program. He specializes in treating patients with primary tumors of the brain, head and neck, and at the base of the skull.
“Due to Yale's large referral base, I frequently see relatively rare tumors,” he says, including low-grade and malignant gliomas, ependymomas, high-grade meningiomas, hemangiopericytomas, paragangliomas, and schwannomas. His expertise in treating uncommon cancers benefits patients diagnosed with these tumor types. “I look forward to helping patients have the best possible outcome when they are faced with a challenging diagnosis,” he says.
Dr. Contessa is a Professor of therapeutic radiology and of pharmacology at Yale School of Medicine where he is part of a team of physicians and scientists who are actively researching the cellular mechanisms that tumors use to evade or “outsmart” standard cancer therapies in hopes of identifying new approaches that improve treatment.
“We are all working together to increase our knowledge, improve our care and beat cancer,” Dr. Contessa says.
Joseph N. Contessa, MD, PhD, a radiation oncologist, is the director of Yale Medicine’s Central Nervous System Radiotherapy Program. He specializes in treating patients with primary tumors of the brain, head and neck, and at the base of the skull.
“Due to Yale's large referral base, I frequently see relatively rare tumors,” he says, including low-grade and malignant gliomas, ependymomas, high-grade meningiomas, hemangiopericytomas, paragangliomas, and schwannomas. His expertise in treating uncommon cancers benefits patients diagnosed with these tumor types. “I look forward to helping patients have the best possible outcome when they are faced with a challenging diagnosis,” he says.
Dr. Contessa is a Professor of therapeutic radiology and of pharmacology at Yale School of Medicine where he is part of a team of physicians and scientists who are actively researching the cellular mechanisms that tumors use to evade or “outsmart” standard cancer therapies in hopes of identifying new approaches that improve treatment.
“We are all working together to increase our knowledge, improve our care and beat cancer,” Dr. Contessa says.
研究兴趣
论文共 121 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Benjamin L. Lampson,Ana S. Ramίrez, Marta Baro, Lixia He,Mudra Hegde, Vidyasagar Koduri, Jamie L. Pfaff, Ruth E. Hanna, Julia Kowal,Nitin H. Shirole, Yanfeng He, John G. Doench,
Cellno. 9 (2024): 2209-2223.e16
SCIENCE ADVANCESno. 11 (2023)
引用0浏览0引用
0
0
Cecilia Lopez Sambrooks,Marta Baro,Amanda Quijano,Azeet Narayan,Wei Cui,Patricia Greninger,Regina Egan, Abhijit Patel,Cyril H. Benes,W. Mark Saltzman,Joseph N. Contessa
crossref(2023)
MOLECULAR CELLno. 24 (2023): 4524-4537.e5
JAMA oncology (2023)
引用0浏览0WOS引用
0
0
International Journal of Radiation Oncology*Biology*Physics (2023)
引用0浏览0引用
0
0
crossref(2023)
Cecilia Lopez Sambrooks,Marta Baro,Amanda Quijano,Azeet Narayan,Wei Cui,Patricia Greninger,Regina Egan, Abhijit Patel,Cyril H. Benes,W. Mark Saltzman,Joseph N. Contessa
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn